Home › Conditions › Visible Haematuria

Urology

Visible Haematuria

Painless visible haematuria must be treated as bladder cancer until proven otherwise. NICE NG12 mandates a 2-week wait (2WW) referral for all visible haematuria in patients aged ≥45 years. Triple assessment (flexible cystoscopy + upper tract CT urogram + urine cytology) is the diagnostic standard.

NICE NG12 2WW Referral / Triple Assessment

The pathway

Characterise the haematuria

NICE NG12 2WW referral criteria

Urine dipstick and MSU

Immediate management: clot retention

Triple assessment

Further investigation

Anticoagulation and haematuria

Drugs

DrugDoseRouteNotes
Normal saline (continuous bladder irrigation)TitratedVia 3-way catheterFor clot retention. Run fast enough to keep drainage clear. Use 3-litre bags.
Tranexamic acidUrology decision, not routinePONot a ward-level decision. Risk of clot retention and ureteric obstruction, particularly with upper-tract bleeding. Only on urology advice, after clot retention has been managed.
Tamsulosin400mcg ODPOIf BPH contributing to outflow obstruction with haematuria.

When to escalate

Reference: NICE NG12 Suspected Cancer Recognition and Referral 2015 / BAUS Haematuria Guidelines 2020

Practise and explore

Practise a case or explore differentials here on the website. The optional browser app adds personal learning tools and saved progress.

Ready for your next shift

Get it on your phone

Free, offline, no account.

Download bleep oncall

The current iPhone release, on the App Store.

Made between shifts

Keep bleep brewing.

Free to use. Ad-free by choice. If bleep has helped you through a shift, you can support what comes next.

Buy me a coffee

A small thank you. Always optional.